National, regional, and state-level pneumonia and severe pneumonia morbidity in children in India: modelled estimates for 2000 and 2015 by Wahl, Brian et al.
678 www.thelancet.com/child-adolescent   Vol 4   September 2020
Articles
Lancet Child Adolesc Health 
2020; 4: 678–87
See Comment page 643
International Vaccine Access 
Center (B Wahl PhD, 
M D Knoll PhD, A Shet MD, 
M Sauer MPH, 
Prof K L O’Brien MD, 
Prof M Santosham MD), 
Institute for International 
Programs (L Liu PhD, 
Prof R E Black MD), and 
Department of Population, 
Family and Reproductive 
Health, Johns Hopkins 
Bloomberg School of Public 
Health (L Liu), Baltimore, MD, 
USA; Department of 
Community Medicine and 
School of Public Health, 
Postgraduate Institute of 
Medical Education and 
Research, Chandigarh, India 
(Prof M Gupta PhD, 
Prof R Kumar MD); Department 
of Sociology, Institute for 
Population Research, Ohio 
State University, Columbus, 
OH, USA (Y Chu MSPH); Centre 
for Global Health, Usher 
Institute, University of 
Edinburgh, Edinburgh, UK 
(Prof H Campbell MD, 
Prof H Nair PhD); Public Health 
Foundation of India, New 
Delhi, India (Prof H Nair); 
Institute of Health and 
Wellbeing, University of 
Glasgow, Glasgow, UK 
(D A McAllister MD); and World 
Health Organization, Geneva, 
Switzerland (Prof K L O’Brien)
Correspondence to: 
Dr Brian Wahl, International 
Vaccine Access Center, Johns 
Hopkins Bloomberg School of 
Public Health, Baltimore, 
MD 21231, USA 
bwahl@jhu.edu
National, regional, and state-level pneumonia and severe 
pneumonia morbidity in children in India: modelled 
estimates for 2000 and 2015
Brian Wahl, Maria Deloria Knoll, Anita Shet, Madhu Gupta, Rajesh Kumar, Li Liu, Yue Chu, Molly Sauer, Katherine L O’Brien, 
Mathuram Santosham, Robert E Black, Harry Campbell, Harish Nair, David A McAllister
Summary
Background The absolute number of pneumonia deaths in India has declined substantially since 2000. However, 
pneumonia remains a major cause of morbidity in children in the country. We used a risk factor-based model to 
estimate pneumonia and severe pneumonia morbidity in Indian states in 2000 and 2015.
Methods In this modelling study, we estimated the burden of pneumonia and severe pneumonia in children younger 
than 5 years using a risk factor-based model. We did a systematic literature review to identify published data on the 
incidence of pneumonia from community-based longitudinal studies and calculated summary estimates. We 
estimated state-specific incidence rates for WHO-defined clinical pneumonia between 2000 and 2015 using Poisson 
regression and the prevalence of risk factors in each state was obtained from National Family Health Surveys. From 
clinical pneumonia studies, we identified studies reporting the proportion of clinical pneumonia cases with lower 
chest wall indrawing to estimate WHO-defined severe pneumonia cases. We used the estimate of the proportion of 
cases with lower chest wall indrawing to estimate WHO-defined severe pneumonia cases for each state.
Findings Between 2000 and 2015, the estimated number of pneumonia cases in Indian HIV-uninfected children 
younger than 5 years decreased from 83·8 million cases (95% uncertainty interval [UI] 14·0–300·8) to 49·8 million 
cases (9·1–174·2), representing a 41% reduction in pneumonia cases. The incidence of pneumonia in children 
younger than 5 years in India was 657 cases per 1000 children (95% UI 110–2357) in 2000 and 403 cases per 
1000 children (74–1408) in 2015. The estimated national pneumonia case fatality rate in 2015 was 0·38% (95% UI 
0·11–2·10). In 2015, the estimated number of severe pneumonia cases was 8·4 million (95% UI 1·2–31·7), with an 
incidence of 68 cases per 1000 children (9–257) and a case fatality ratio of 2·26% (0·60–16·30). In 2015, the estimated 
number of pneumonia cases in HIV-uninfected children was highest in Uttar Pradesh (12·4 million [95% UI 
2·1–45·0]), Bihar (7·3 million [1·3–26·1]), and Madhya Pradesh (4·6 million [0·7–17·0]). Between 2000 and 2015, the 
greatest reduction in pneumonia cases was observed in Kerala (82% reduction). In 2015, pneumonia incidence was 
greater than 500 cases per 1000 children in two states: Uttar Pradesh (565 cases per 1000 children [95% UI 94–2047]) 
and Madhya Pradesh (563 cases per 1000 children [88–2084]).
Interpretation The estimated number of pneumonia and severe pneumonia cases among children younger than 
5 years in India decreased between 2000 and 2015. Improvements in socioeconomic indicators and specific 
government initiatives are likely to have contributed to declines in the prevalence of pneumonia risk factors in many 
states. However, pneumonia incidence in many states remains high. The introduction of new vaccines that target 
pneumonia pathogens and reduce risk factors will help further reduce the burden of pneumonia in the country.
Funding Bill & Melinda Gates Foundation.
Copyright © 2020 The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY-NC-ND 4.0 
license.
Introduction
Efforts to improve access to primary health services in 
India have contributed to substantial reductions in 
pneumonia mortality in the past decade; however, 
pneumonia remains the leading cause of mortality in 
children after the neonatal period in the country.1 In 
2015, there were an estimated 192 000 pneumonia deaths 
in children younger than 5 years, representing a 57% 
reduction in pneumonia mortality since 2000.1 As deaths 
attributed to pneumonia continue to decline, reducing 
the burden of pneumonia morbidity through primary 
interventions in particular will become increasingly 
important. Updated subnational estimates of pneumonia 
morbidity can help to monitor progress in this regard.
WHO has identified several interventions for the 
prevention of pneumonia in children.2 Many of these 
interventions are associated with improving nutrition 
and reducing exposure to environmental and social risk 
factors, including exclusive breastfeeding for the first 
6 months of life, adequate complementary feeding, 
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vitamin A supplementation, handwashing with soap, 
reducing exposure to indoor air pollution, and immuni­
sation.2 The urgent need to focus on pneumonia 
prevention is compounded by the increasing prevalence 
of antibiotic resistance that threatens to make the 
treatment of bacterial causes of pneumonia more 
challenging and expensive in countries such as India.3
Aetiological contributors to pneumonia morbidity 
globally include Streptococcus pneumoniae (pneu­
mococcus), Haemophilus influenzae type b (Hib), 
respiratory syncytial virus, influenza, and human 
metapneumovirus.4,5 India introduced the Hib­containing 
pentavalent vaccine in two states in 2011.6 According to 
the International Vaccine Center’s VIEW­hub, the vaccine 
is now used routinely in all states and union territories in 
India. The 13­valent pneumococcal conjugate vaccine 
was introduced in three states in 2017, which was 
expanded to three additional states in 2018 with plans to 
expand its routine use in coming years.5 The Indian 
Government is also currently implementing other 
programmes that could reduce the burden of pneumonia 
in India, including the Integrated Child Development 
Services scheme that aims to improve the nutritional 
status of children7 and the Mothers’ Absolute Affection 
programme, which promotes exclusive breastfeeding 
during the first 6 months of life.8
Previous national and subnational estimates of 
pneumonia morbidity for India have been published.9,10 
Using subnational input data, researchers estimated 
there were 3·6 million severe pneumonia cases in 2010 
in children younger than 5 years in India.10 This model 
used a risk factor­based approach originally developed by 
WHO and the Maternal and Child Epidemiology 
Estimation (WHO/MCEE) collaboration.11 Using a 
similar approach, the WHO/MCEE estimated that 
nationally there were 45·0 million pneumonia cases and 
7·2 million severe pneumonia cases among children in 
India in 2015.12 For simplicity, these models assumed that 
the prevalence of pneumonia risk factors were 
independent—eg, children who had a low birthweight 
are no more likely to have malnutrition than children 
who did not have low birthweight. To support policy 
making associated with child health interventions in 
India, we used a method that instead uses the observed 
risk factor combinations to calculate pneumonia and 
severe pneumonia morbidity in Indian states between 
2000 and 2015.
Methods
Literature review
We estimated the burden of pneumonia and severe 
pneumonia using a risk factor­based model, which has 
been described previously.12 Briefly, we used data from 
a 2018 systematic literature review that identified 
published data on the incidence of pneumonia from 
community­based longitudinal studies around the world 
Research in context
Evidence before this study
We searched PubMed for modelled national and subnational 
estimates of pneumonia and severe pneumonia morbidity in 
children in India published between Jan 1, 2000, and 
Dec 31, 2018, using the search terms “pneumonia”, “respiratory 
infection”, “India”, and “model”. We included estimates of lower 
respiratory infections and severe lower respiratory infections in 
our search. Several national estimates of pneumonia and severe 
pneumonia morbidity have been published by the Child Health 
Epidemiology Reference Group collaboration (now the WHO 
Maternal and Child Epidemiology Estimation collaboration). 
Based on the most contemporary of these estimates published 
in 2018, there were approximately 45 million cases of 
pneumonia and 7 million cases of severe pneumonia in 2015. 
National and subnational estimates of severe pneumonia 
morbidity for 2010 were published in 2015. Based on these 
estimates, there were 3·6 million severe pneumonia cases in 
India in 2010. In the same paper, the researchers published 
estimates of deaths due to pneumonia in 2010, corresponding 
to a case fatality ratio of approximately 1% for children younger 
than 5 years.
Added value of this study
To our knowledge, our findings represent the most up to date 
estimates of national pneumonia and severe pneumonia 
morbidity in India. Although estimates of severe pneumonia 
cases in India have been published previously, we believe that 
these are also the first subnational estimates for pneumonia 
and severe pneumonia to be presented together. Additionally, 
we have updated our risk factor prevalence-based model used 
to derive pneumonia case estimates. Our updated model uses 
seven risk factors for pneumonia instead of the five or six risk 
factors used in previous models. Earlier models assumed that 
pneumonia risk factors were independent. The completeness 
of the India survey data allowed us to directly measure the 
number of children with each combination of risk factors 
using individual-level survey data, which enabled us to build 
the risk factor model using the observed correlation between 
risk factors.
Implications of all the available evidence
These updated estimates reflect the reductions in pneumonia 
and severe pneumonia morbidity in India since 2000, as a 
result of changes in the prevalence of seven pneumonia risk 
factors. These data, together with all the available evidence, 
should be used to inform policies and programmes that target 
pneumonia morbidity in India. Additionally, the methods 
developed for this study can be used as a framework to model 
data from other settings.
For more on the International 
Vaccine Center’s VIEW-hub see 
https://www.view-hub.org
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to identify summary estimates of risk factors associated 
with pneumonia in children.12 Only studies that reported 
the incidence of WHO­defined clinical cases of 
pneumonia in children younger than 5 years and those 
that were done for a minimum of 1 year and in multiples 
of 12 months to account for seasonal variations in 
incidence were included in the model. From clinical 
pneumonia studies, the earlier review identified studies 
that reported the proportion of clinical pneumonia cases 
with lower chest wall indrawing to estimate WHO­
defined severe pneumonia cases. For pneumonia 
risk factors, we used summary estimates from a 
previous review13 that identified factors associated with 
pneumonia (table 1). Details of the literature review are 
listed in the appendix (pp 3–5).
Data analysis
Model parameters and data sources are shown in table 1. 
We obtained data on the prevalence of identified risk 
factors (with the exception of HIV infection) in each state 
from the National Family Health Survey, which uses 
standardised Demographic and Health Survey data 
collection methods.15 This survey is intended to be done 
every 5 years in India and provides data on a range of 
demographic and health indicators. For small states that 
were not included in National Family Health Surveys, we 
used prevalence estimates from neighbouring states with 
similar demographics. The prevalence of HIV infection 
in children was estimated using the proportion of 
children in each state with mothers infected with HIV 
and the UNAIDS estimate of the odds ratio for HIV 
infection in children born to mothers with HIV infection 
in India. We used India census data from 2001 and 2011 
to estimate annual population growth rates for each 
state, which were extrapolated to 2015.16 We normalised 
population data to sum to the total national UN 
population estimates for India.
We estimated state­specific pneumonia incidence by 
combining overall incidence estimates from published 
papers for the WHO South­East Asia region, published 
effect estimates for associations between risk factors and 
pneumonia, and risk factor prevalence data from state­
level survey data. We combined each of these estimates 
in a risk­factor based model, sampling from our previous 
model,12 log­normal distributions, and Dirichlet distri­
butions for the regional incidence, risk factor 
associations, and survey data. We also calculated the 
incidence of clinical pneumonia in children with HIV 
and incidence of pneumonia attributable to HIV. We 
applied the estimate of the proportion of cases with lower 
chest wall indrawing to state­level WHO­defined clinical 
pneumonia cases for each state. Additional details about 
the model are in the appendix (pp 3–5).
After calculating pneumonia and severe pneumonia 
cases for each state, we used estimates of Hib vaccine 
efficacy against invasive Hib disease,17 the proportion of 
clinical pneumonia cases attributable to Hib,18 and 
state­level vaccine coverage estimates in a post­hoc 
adjustment to account for the proportion of children who 
would have been protected by the Hib vaccine. We used 
coverage of the third dose of diphtheria–tetanus–
pertussis vaccine from subnational surveys for coverage 
with three doses of Hib vaccine. This approach is justified 
because Hib vaccine, when and where used, is provided 
as part of a pentavalent combination that includes 
diphtheria–tetanus–pertussis vaccination in the national 
immuni sation programme. We adjusted coverage 
estimates to account for the time of year that Hib vaccine 
was introduced. Linear interpolation was used when data 
were missing for relevant years. Pneumococcal conjugate 
vaccine was only available in India in the private sector in 
2015 with low estimated population­level coverage.19 
Therefore, we assumed pneumococcal conjugate vaccine See Online for appendix
Data sources Summary estimate
Pneumonia and severe pneumonia morbidity
Baseline pneumonia 
incidence in the 
community 
(per child-year)
Published summary 
estimate12
0·22 (IQR 0·11–0·51)
Proportion of severe 
pneumonia cases
Published summary 
estimate12
11·5% (IQR 8·0–33·0)
Pneumonia risk factors
Low birthweight 
(<2·5 kg)
Published summary 
estimate13
OR 3·6 (95% CI 0·8–16·3)
Lack of exclusive 
breastfeeding for the 
first 6 months of life
Published summary 
estimate13
OR 2·7 (95% CI 1·7–4·4)
Crowding (seven or 
more individuals per 
household)
Published summary 
estimate13
OR 1·9 (95% CI 1·5–2·5)
Indoor air pollution 
exposure
Published summary 
estimate13
OR 1·6 (95% CI 1·1–2·3)
Malnutrition 
(weight-for-age 
≤2 SDs)
Published summary 
estimate13
OR 4·5 (95% CI 2·1–9·5)
Incomplete 
immunisation at 
12 months
Published summary 
estimate13
OR 1·8 (95% CI 1·3–2·5)
HIV infection Published summary 
estimate14
OR 6·5 (95% CI 5·9–7·2)
Population at risk and demographic model parameters
Child population 2001 and 2011 
census data from the 
Government of India
State-specific values
Hib vaccine coverage Inferred from DTP3 
coverage estimates 
from AHS, DLHS, and 
NFHS
State-specific values
Pneumonia 
mortality
Estimates of 
pneumonia 
mortality from 
WHO/MCEE 
collaboration1
State-specific values
 OR=odds ratio. Hib=Haemophilus influenzae type b. DTP3=third dose of 
diphtheria–tetanus–pertussis vaccine. AHS=Annual Health Survey. DLHS=District 
Level Household and Facility Survey. NFHS=National Family Health Survey. 
WHO/MCEE=WHO and the Maternal Child Epidemiology Estimation. 
Table 1: Model parameters, data sources, and summary estimates
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had no impact on pneumonia morbidity in children 
before 2015. We used published state­level estimates 
of pneumonia deaths in children from 20151 to 
independently infer case fatality ratios.
Using state­level estimates of pneumonia mortality for 
2015 published by the WHO/MCEE collaboration,1 we 
estimated pneumonia and severe pneumonia case 
fatality ratios in all states in 2000 and 2015.
We used a simulation approach to calculate state­
specific rates and corresponding uncertainty estimates, 
presented as uncertainty intervals (UIs; appendix p 5). 
All statistical analyses were done using R (version 3.2) 
and JAGS (version 3.4) software. Code for the updated 
model is available online.
Reporting
For the purpose of this analysis, we report pneumonia 
and severe pneumonia morbidity estimates for six 
geographically contiguous and socioeconomically similar 
regions: north, east, northeast, central, west, and south. 
For state­level reporting, union territories, with the 
exception of Delhi, and states in the northeast, with the 
exception of Assam, have been grouped together. 
Telangana separated from Andhra Pradesh in June, 2014. 
We projected population and mortality data for Andhra 
Pradesh and modelled the pneumonia and severe 
pneumonia burden for Andhra Pradesh and Telangana 
together for 2015. We report on the pneumonia and 
severe pneumonia morbidity together for nine states 
with high infant mortality that together have been 
designated as high­focus states by the Government of 
India (table 2). The state and regional estimates are 
related to the total estimate only through the estimated 
rate in the unexposed group (ie, children without 
pneumonia risk factors). The state counts will therefore 
not sum to the national counts. This study was done in 
accordance with the Guidelines for Accurate and 
Transparent Health Estimates Reporting (GATHER) 
recommendations (appendix p 2).20
Role of the funding source
The funder of this study had no role in the study design, 
data collection, data analysis, data interpretation, writing 
of the report, or the decision to submit this report for 
publication. All authors had full access to all the data 
used in the study and the corresponding author had final 
responsibility for the decision to submit for publication.
Results
In 2015, 49·8 million pneumonia cases (95% UI 
9·1–174·2) were estimated to have occurred in HIV­
uninfected children younger than 5 years in India. At the 
national level, pneumonia cases declined by 41% since 
2000, when there were an estimated 83·8 million 
pneumonia cases (14·0–300·8) in this age group. 
Between 2000 and 2015, at the national level, pneumonia 
incidence in HIV­uninfected children younger than 
5 years in India decreased by 39% from 657 cases per 
1000 children (95% UI 110–2357) to 403 cases per 
1000 children (74–1408). In 2015, there were an estimated 
8·4 million (95% UI 1·2–31·7) cases of severe pneumonia 
in children younger than 5 years with a corresponding 
incidence rate of 68 cases per 1000 children (9–257).
In 2015, the pneumonia incidence in the central 
region in children younger than 5 years (540 cases per 
1000 children [95% UI 89–1967]) was more than twice 
that of the incidence in the south region (251 cases per 
1000 children [55–810]). The estimated decline in 
pneumonia incidence between 2000 and 2015 was 
highest in the north region (53%): pneumonia incidence 
in the west region reduced by 22% during the same 
time period. The central region also had the greatest 
estimated severe pneumonia incidence in children 
younger than 5 years (91 cases per 1000 children [95% UI 
11–355]) in 2015.
In 2015, the estimated incidence of pneumonia in 
children younger than 5 years was higher in the high­
focus states (513 cases per 1000 children [95% UI 
87–1847]) than the non­high­focus states (331 cases per 
1000 children [64–1134]). Pneumonia incidence in high­
focus states declined by approximately the same amount 
as non­high­focus states between 2000 and 2015. In 2015, 
the incidence of severe pneumonia in high­focus states 
was 87 cases per 1000 children (95% UI 11–336) compared 
with 56 cases per 1000 children (8–208) in non­high­
focus states.
The incidence and number of cases of pneumonia and 
severe pneumonia for each state in 2000 and 2015 are 
shown in table 3. In 2015, the highest estimated number 
of pneumonia cases in children uninfected with HIV 
occurred in Uttar Pradesh (12·4 million [95% UI 
2·1–45·0]), Bihar (7·3 million [1·3–26·1]), and Madhya 
Pradesh (4·6 million [0·7–17·0]). In all states, the 
States
Central Chhattisgarh, Madhya Pradesh, Rajasthan, and Uttar 
Pradesh
East Bihar, Jharkhand, Odisha, and West Bengal
North Chandigarh, Delhi, Haryana, Himachal Pradesh, Jammu and 
Kashmir, Punjab, and Uttarakhand
Northeast* Arunachal Pradesh, Assam, Manipur, Meghalaya, Mizoram, 
Nagaland, Sikkim, and Tripura
South Andaman and Nicobar Islands, Andhra Pradesh, Karnataka, 
Kerala, Lakshadweep, Puducherry, and Tamil Nadu
West Dadra and Nagar Haveli, Daman and Diu, Goa, Gujarat, and 
Maharashtra
Union 
territories
Andaman and Nicobar Islands, Chandigarh, Dadra and 
Nagar Haveli, Daman and Diu, Delhi, Lakshadweep, and 
Puducherry
High-focus 
states†
Assam, Bihar, Chhattisgarh, Jharkhand, Madhya Pradesh, 
Odisha, Rajasthan, Uttar Pradesh, and Uttarakhand
*Northeast states exclude Assam for state-level estimates. †States with high 
infant mortality are designated as high-focus states by the Government of India.
Table 2: Indian states by region and categories
For the model code see 
https://github.com/
ChronicDiseaseEpi/india_
pneumonia_estimates/
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estimated number of pneumonia cases decreased 
between 2000 and 2015. The greatest reduction was 
observed in Kerala (73% reduction) and the smallest 
reduction was observed in Gujarat (18% reduction) 
during this time period. In 2015, pneumonia incidence 
was greater than 500 cases per 1000 children in 
two states: Uttar Pradesh (565 cases per 1000 children 
[95% UI 94–2047]) and Madhya Pradesh (563 cases per 
1000 children [88–2084]; figure 1).
In 2015, there were an estimated 143 000 cases (95% UI 
23 000–530 000) of pneumonia and 24 000 cases 
(3000–95 000) of severe pneumonia among children with 
HIV, and the incidence of pneumonia and severe 
pneumonia among children with HIV was highest in 
Uttar Pradesh (4673 cases of pneumonia per 1000 children 
with HIV [652–17 877] and 791 cases of severe pneumonia 
per 1000 children with HIV [85–3293]). Between 
2000 and 2015, the incidence of pneumonia and severe 
2000 2015
Pneumonia cases* 
(95% UI)
Pneumonia 
incidence 
(95% UI)
Severe 
pneumonia cases* 
(95% UI)
Severe 
pneumonia 
incidence 
(95% UI)
Pneumonia cases* 
(95% UI)
Pneumonia 
incidence 
(95% UI)
Severe 
pneumonia cases* 
(95% UI)
Severe 
pneumonia 
incidence 
(95% UI)
States
Andhra Pradesh 
and Telangana
3920 (700–13 680) 504 (90–1 758) 660 (90–2 510) 85 (11–323) 1830 (380–6110) 275 (57–918) 310 (50–1120) 46 (7–169)
Assam 2000 (340–7220) 574 (98–2068) 340 (40–1300) 97 (13–371) 1250 (250–4 230) 350 (69–1184) 210 (30–780) 59 (9–218)
Bihar 10 860 (1730–39 510) 865 (138–3148) 1840 (220–7250) 147 (18–578) 7330 (1290–26 060) 498 (87–1773) 1240 (160–4720) 84 (11–321)
Chhattisgarh 2520 (380–9320) 892 (136–3294) 430 (50–1710) 151 (17–603) 1120 (200–3960) 401 (71–1416) 190 (30–730) 68 (9–260)
Delhi 900 (150–3180) 566 (97–1997) 150 (20–580) 96 (13–364) 430 (80–1480) 285 (54–983) 70 (10–280) 48 (7–184)
Goa 70 (10–230) 542 (91–1943) 10 (0–40) 92 (12–356) 20 (0–70) 203 (44–667) 0 (0–10) 34 (6–124)
Gujarat 3620 (610–12 900) 596 (101–2123) 610 (80–2380) 101 (13–391) 2960 (500–10 770) 493 (83–1792) 500 (60–1960) 83 (11–326)
Haryana 1420 (240–5050) 540 (92–1926) 240 (30–930) 91 (12–353) 850 (170–2870) 326 (65–1100) 140 (20–530) 55 (8–205)
Himachal 
Pradesh
330 (60–1170) 502 (87–1801) 60 (10–210) 85 (11–327) 190 (40–650) 320 (60–1112) 30 (0–120) 54 (8–206)
Jammu and 
Kashmir
690 (110–2450) 642 (107–2282) 120 (10–450) 109 (14–422) 390 (90–1240) 218 (49–695) 70 (10–230) 37 (6–131)
Jharkhand 3240 (520–11 780) 865 (138–3148) 550 (70–2160) 147 (18–578) 1920 (340–6720) 464 (83–1625) 320 (40–1220) 78 (11–296)
Karnataka 3130 (560–10 690) 548 (99–1873) 530 (70–1990) 93 (12–349) 2000 (380–6820) 362 (69–1235) 340 (50–1260) 61 (9–228)
Kerala 1300 (250–4360) 402 (79–1346) 220 (30–800) 68 (10–248) 350 (100–930) 137 (40–365) 60 (10–180) 23 (5–69)
Madhya 
Pradesh
7600 (1150–28 050) 892 (136–3294) 1290 (150–5140) 151 (17–603) 4590 (720–16 990) 563 (88–2084) 780 (90–3060) 95 (12–375)
Maharashtra 6320 (1100–22 240) 572 (99–2012) 1070 (140–4060) 97 (13–368) 4350 (770–15 520) 431 (76–1538) 740 (100–2810) 73 (10–279)
Northeast 800 (140–2830) 540 (94–1900) 140 (20–520) 91 (12–351) 420 (100–1280) 248 (60–750) 70 (10–240) 42 (7–139)
Odisha 2570 (430–9140) 622 (104–2215) 430 (60–1680) 105 (13–408) 1580 (280–5540) 394 (71–1386) 270 (40–1020) 67 (9–254)
Punjab 1420 (230–5140) 576 (93–2086) 240 (30–950) 98 (12–385) 600 (120–2040) 258 (50–879) 100 (10–380) 44 (6–164)
Rajasthan 6930 (1090–25 310) 828 (130–3026) 1170 (140–4590) 140 (17–549) 3970 (650–14 520) 499 (81–1826) 670 (80–2630) 84 (10–331)
Tamil Nadu 2420 (460–8200) 411 (78–1395) 410 (60–1520) 70 (10–259) 980 (260–2850) 169 (44–491) 170 (30–540) 29 (6–92)
Union 
territories
150 (30–530) 526 (91–1859) 30 (0–100) 89 (12–342) 80 (20–260) 257 (54–857) 10 (0–50) 43 (7–158)
Uttar Pradesh 20 120 (3200–73 050) 838 (133–3041) 3410 (410–13 410) 142 (17–558) 12 410 (2070–44 960) 565 (94–2047) 2100 (270–8130) 96 (12–370)
Uttarakhand 890 (140–3240) 838 (133–3041) 150 (20–600) 142 (17–558) 320 (60–1120) 321 (60–1118) 50 (10–210) 54 (8–206)
West Bengal 5650 (930–20 270) 638 (105–2291) 960 (120–3730) 108 (13–421) 2590 (500–8880) 331 (64–1133) 440 (60–1630) 56 (8–208)
Regions
Central 37 170 (5850–135 840) 850 (134–3105) 6290 (750–24 700) 144 (17–565) 22 090 (3630–80 430) 540 (89–1967) 3740 (470–14 530) 91 (11–355)
East 22 310 (3620–80 490) 762 (124–2749) 3780 (460–14 800) 129 (16–506) 13 420 (2410–47 090) 437 (79–1534) 2270 (310–8620) 74 (10–281)
North 5700 (950–20 340) 596 (99–2127) 960 (120–3720) 101 (13–389) 2790 (560–9420) 282 (56–952) 470 (70–1760) 48 (7–177)
Northeast 2810 (480–10 020) 564 (97–2010) 480 (60–1810) 95 (12–363) 1670 (350–5490) 317 (67–1040) 280 (40–1020) 54 (8–193)
South 10 830 (2000–37 230) 476 (88–1636) 1830 (250–6840) 81 (11–301) 5180 (1140–16 750) 251 (55–810) 880 (140–3100) 42 (7–150)
West 10 040 (1730–35 380) 580 (100–2044) 1700 (220–6520) 98 (13–377) 7370 (1270–26 360) 453 (78–1619) 1250 (160–4780) 77 (10–294)
National† 83 830 (14 000–300 800) 657 (110–2357) 14 190 (1790–54 730) 111 (14–429) 49 800 (9100–174 180) 403 (74–1408) 8430 (1170–31 730) 68 (9–257)
Incidence rates are cases per 1000 children younger than 5 years. UI=uncertainty interval. *Data are in thousands. †Since state and region estimates are related to the total estimate only through the estimated 
rate in the unexposed group (ie, children without pneumonia risk factors), the state counts will not sum to the national counts.
Table 3: National-level and state-level estimates of pneumonia and severe pneumonia morbidity in Indian children younger than 5 years
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pneumonia in children with HIV increased in Rajasthan, 
Jharkhand, Bihar, Odisha, Jammu and Kashmir, and 
Haryana (appendix pp 18–19).
In 2015, the estimated national pneumonia case fatality 
rate was 0·38% (95% UI 0·11–2·10) and the estimated 
severe pneumonia case fatality rate was 2·26% 
(0·60–16·30). In 2015, pneumonia case fatality rates 
ranged from 0·87% (0·26–4·37) in Assam to 0·12% 
(0·03–0·69) in Maharashtra. Severe pneumonia case 
fatality rates ranged from 5·20% (1·40–36·42) in Assam 
to 0·72% (0·19–5·31) in Maharashtra (appendix p 17). 
Pneumonia mortality decreased in all states between 
2000 and 2015.
The national prevalence of all seven pneumonia risk 
factors, with the exception of non­exclusive breast­
feeding, decreased between 2000 and 2015 (figure 2). The 
prevalence of non­exclusive breastfeeding increased 
from 20% to 22% between 2000 and 2015. The prevalence 
of HIV infection was estimated to be the lowest of all 
pneumonia risk factors (0·3% in both 2000 and 2015). 
National prevalence of malnutrition decreased margin­
ally; however, the prevalence of malnutrition in many of 
the high­focus states largely remained constant or 
increased, with the exception of Rajasthan and Odisha, 
in which the malnutrition prevalence decreased by 8% 
and 7%, respectively. The prevalence of incomplete 
immunisation decreased more than the other 
six pneumonia risk factors from 25% to 19% between 
2000 and 2015. The range of prevalence estimates for 
indoor air pollution at the state level increased 
substantially between 2000 and 2015.
Discussion
We calculated national­level and state­level estimates of 
pneumonia and severe pneumonia morbidity for India 
between 2000 and 2015 using an updated risk factor­
based approach. To our knowledge, these estimates 
represent the first subnational pneumonia morbidity 
estimates and the most contemporary severe pneumonia 
morbidity estimates for India. Together with pneumonia 
mortality estimates prepared by the WHO/MCEE 
collaboration,1 these estimates can be used by policy 
makers to track progress toward reducing the burden of 
pneumonia and prioritising the introduction of new 
child health interventions. Furthermore, these estimates 
could be used to estimate the cost­effectiveness of 
pneumonia interventions.
We estimate that pneumonia and severe pneumonia 
cases in India decreased by approximately 41% between 
2000 and 2015, which is greater than the 22% reduction 
in pneumonia cases observed globally during the same 
period.12 The reduction in India corresponds to an overall 
reduction in the proportion of children who are not 
immunised and state­specific reductions in low birth­
weight, malnutrition, and exposure to indoor air 
pollution. Many risk factors for pneumonia are associated 
with low socioeconomic status. Although considerable 
socioeconomic inequities remain in India, overall 
improvements in socioeconomic status would have 
contributed to a reduction in the prevalence of important 
risk factors for pneumonia.
Additionally, the launch of the National Rural Health 
Mission in 2005 (now the National Health Mission) has 
helped to expand and improve access to many primary 
health services for women and children in the country, 
including immunisation.21,22 Researchers have also found 
that nutrition outcomes have been improving in several 
states in India at least partly due to improved infant 
and young child feeding practices encouraged by 
the Integrated Child Development Services programme.23 
Additional govern ment efforts aimed at addressing the 
prevalence of risk factors for pneumonia morbidity, 
including Mission Indradhanush to improve full immuni­
sation coverage and Pradhan Mantri Ujjwala Yojana to 
extend access to liquid petroleum gas and therefore reduce 
exposure to indoor air pollution, could help further reduce 
the burden of pneumonia morbidity in the country.
Despite these reductions, considerable disparities in 
pneumonia morbidity remain between states in India. 
These disparities arise largely as a result of substantial 
differences in the prevalence of risk factors for 
pneumonia. All states in India had introduced the Hib­
containing pentavalent vaccine by December, 2015. 
Figure 1: Incidence of WHO-defined clinical pneumonia in India in 2015 by state*
*Andhra Pradesh and Telangana were calculated together.
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However, the states with the lowest pneumonia burden 
(Kerala and Tamil Nadu) were the first to introduce the 
vaccine in 2012. Many high burden states did not 
introduce the vaccine until 2015. Uttar Pradesh, the 
state with the highest estimated incidence of 
pneumonia and severe pneumonia, introduced the 
pentavalent vaccine in December, 2015. Additionally, 
differences in care­seeking behaviours between states 
are also likely to have contributed to disparities in the 
case fatality ratios estimated using state­level estimates 
of pneumonia mortality for 2015 from the WHO/MCEE 
collaboration.1
Although the prevalence of pneumonia risk factors in 
many states declined between 2000 and 2015, in many 
states the prevalence of many risk factors increased or 
remained stable, and thus should be the target of 
strategies to address the burden of pneumonia in India. 
The strategy used for the introduction of pneumococcal 
conjugate vaccine in 2017, in Uttar Pradesh, Bihar, and 
Himachal Pradesh—some of the states with the highest 
pneumonia incidence—differed from the strategy used 
for Hib vaccine which was introduced first in Tamil Nadu 
and Kerala. The introduction of pneumococcal conjugate 
vaccine in Uttar Pradesh and Bihar was initiated in 
several districts in these states. In the future, district­
level estimates of pneumonia burden will be helpful for 
policy making with regard to the introduction of new 
vaccines that target respiratory pathogens including 
respiratory syncytial virus and influenza.
The 2015 national estimates of pneumonia and severe 
pneumonia of approximately 49·8 million and 8·4 million 
cases, respectively, are marginally higher than previously 
published pneumonia and severe pneumonia estimates 
(45·0 million and 7·2 million cases, respectively).12 Our 
2015 estimates allow for correlation of pneumonia risk 
factors (ie, the previous model assumed independence of 
risk factors). As such, we would expect higher estimates, 
assuming all other factors remain constant, in settings 
with high correlation between risk factors. Additionally, 
our 2015 severe pneumonia estimates are also greater 
than the national estimates published for 2010.10 At the 
state­level, the number and incidence of severe pneumonia 
cases also differ substantially—the current estimates are 
higher than those for 2010 for all states. Although the rank 
order of states by the number of severe pneumonia cases 
is similar between the two models, the rank order by 
Figure 2: Prevalence of risk factors for pneumonia in India and high-focus* states (2000–15)
States with high infant mortality are designated as high-focus states by the Government of India. *Risk factor prevalence data for Chhattisgarh, Jharkhand, and 
Uttarakhand in 2000 are unavailable as they were part of Madhya Pradesh, Bihar, and Uttar Pradesh, respectively, until late 2000.
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incidence differs substantially. This suggests differences 
in the denominator used to calculate incidence rates. The 
previously published estimates used a summary estimate 
comprising radiography­confirmed pneumonia rather 
than WHO­defined severe pneumonia to calculate severe 
pneumonia cases. The incidence of radiography­con­
firmed pneumonia from the three studies comprising the 
summary estimate24–26 are lower than the severe pneu­
monia incidence.
In 2016, a prospective and cross­sectional study was 
done in India, which provided estimates of community­ 
acquired pneumonia incidence for 2016 for Bihar and 
Uttar Pradesh.27 In two districts in Uttar Pradesh, the 
estimated incidence of community­acquired pneumonia 
was 87 cases and 177 cases per 1000 children. The 
estimated incidence in two districts in Bihar was 208 and 
221 cases per 1000 children. In our study, the estimated 
incidence of pneumonia among children younger than 
5 years was 524 cases per 1000 children in Uttar Pradesh 
and 495 cases per 1000 children in Bihar. The authors 
suggest that their estimates are likely to underestimate 
the true incidence of community­acquired pneumonia in 
the four districts of these two states. The authors also 
noted that gender biases associated with access to care 
and patients with pneumonia dying before reaching 
a health facility might have contributed to the 
underestimation of community­acquired pneumonia 
incidence in these two states.
We updated the methods of our previous model used 
to estimate pneumonia and severe pneumonia cases. 
First, our updated model includes seven risk factors for 
pneumonia instead of the five or six risk factors used in 
previous models.9,10 Our earlier models also assumed 
that the risk factors were mutually exclusive (eg, a child 
with malnutrition did not also have low birthweight), 
with later models making the less stringent assumption 
that the risk factors were independent. The completeness 
of the India survey data, however, allowed us to directly 
measure the number of children with each combination 
of risk factors using individual­level survey data. 
Therefore, with the exception of HIV infection, we were 
able to build the risk factor model using the observed 
correlation between risk factors. For HIV, we assumed 
that within each state and combination of risk factors, 
the number of children with HIV was proportionally 
related to the proportion of children whose mothers 
had HIV.
We accounted for several sources of uncertainty in our 
estimates of pneumonia morbidity, including pneumonia 
incidence rates, the proportion of pneumonia cases that 
were severe, odds ratios for pneumonia risk factors, the 
proportion of children with pneumonia risk factors, and 
coverage of the pneumococcal conjugate vaccine and Hib 
vaccine in children. The wide UIs reported reflect the 
multiple sources of uncertainty in our model. However, 
these uncertainty estimates might be too conservative. 
For example, the upper UI for pneumonia cases in 2015 
in India was estimated to be 174 million. This exceeds the 
total population in this age group of approximately 
119 million children.28 Improved methods for estimating 
uncertainty from all potential sources of uncertainty, or 
preferably increased empirical data collection, could help 
to address this issue.
The post­hoc adjustment for immunisation with the 
Hib vaccine assumes homogeneous vaccine coverage 
within each state. However, established differences in 
vaccine coverage exist within states and based on 
demographic and socioeconomic indicators.29 Over­
looking these disparities in immunisation coverage is 
likely to result in an overestimation of the impact of 
vaccination and an underestimation of the burden of 
pneumonia morbidity in each of the Indian states. 
Subnational pneumococcal conjugate vaccine coverage 
estimates from the private sector were published for 
2012.19 However, we did not use these estimates in our 
model since the overall national coverage was reported 
to be less than 1% for 2012. Additionally, children who 
received pneumococcal conjugate vaccine through the 
private sector are likely to be at lower risk of 
pneumococcal disease compared with those who did not 
receive pneumococcal conjugate vaccine in the private 
sector.
Our model accounts for the prevalence of indoor air 
pollution as an independent risk factor for pneumonia. 
However, we were unable to account for the prevalence 
of exposure to ambient air pollution, which has been 
observed to be associated with short­term and long­term 
increased risk of pneumonia in children.30 Considering 
the high prevalence of ambient air pollution exposure in 
India, this omission could lead to an under estimation in 
our pneumonia morbidity estimates. Additionally, we 
were unable to account for the increased risk associated 
with having a family member with an upper or lower 
respiratory infection, which are known risk factors for 
pneumonia in India.31,32
India has made substantial progress toward reducing 
childhood pneumonia mortality in the past 15 years. The 
country has the largest population of children younger 
than 5 years worldwide. This cohort of children will soon 
become the largest working population in the world. 
Ensuring that these children are able to live healthy, 
productive lives will require the scale­up of a 
comprehensive package of important interventions that 
protect against and prevent pneumonia, including 
breastfeeding for the first 6 months of life, adequate 
nutrition, immunisation with pertussis, measles, Hib, 
and pneumococcal conjugate vaccine, and interventions 
that reduce exposure to air pollution. Increasing 
utilisation of these interventions will protect many of the 
children most at risk for pneumonia and could help 
prevent long­term sequelae, including restrictive lung 
disease, obstructive lung disease, and asthma.33 These 
interventions are crucial for the future health and 
economic prosperity in India.
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